<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F346FCF6-C584-440C-8397-9FADB1FD5353"><gtr:id>F346FCF6-C584-440C-8397-9FADB1FD5353</gtr:id><gtr:firstName>Olivia</gtr:firstName><gtr:surname>Finney</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081994"><gtr:id>B1CCC08E-1115-4A86-A181-A51D36CC190E</gtr:id><gtr:title>Characterisation of T regulatory cells in malaria exposed Gambians</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081994</gtr:grantReference><gtr:abstractText>Malaria is one of the most common diseases in African children, and a major health problem in The Gambia. Though most cases of malaria are usually mild, severe cases of malaria do also occur, killing approximately one million people each year worldwide. It is thought that clearing the parasite from the body requires a potent effective immune response early during infection. However, an excessive or prolonged immune response can lead to disease. It is therefore important to balance the control of the infection and the control of the immune system. We will study cells that regulate immune responses and see whether they are important to control malaria infection. We will also like to find out how these cells function, and how they are induced. This may allow us to find new treatments or a vaccine that can prevent severe forms of malaria in the future.</gtr:abstractText><gtr:technicalSummary>The important contribution of cell mediated inflammatory responses to control parasite replication in human P. falciparum malaria, and the paramount importance of IFN? in this response, is well established. Equally, sustained and/or excessive inflammatory responses have been conclusively linked to severe pathology in animal malaria models and in human disease. This has led to the hypothesis that the ability to down-regulate inflammatory responses once parasitaemia is under control is crucial to avoid immune mediated pathology and may therefore be an important feature of clinical immunity. Regulatory T cells have been shown to downregulate the immune response in several different models of human disease. Observations made in murine models indicate that these cells may also play a role in malaria infection. In humans, data derived from sporozoite challenged volunteers demonstrate that Foxp3 expressing CD4+CD25+ regulatory T cells can be induced and activated as early as 10 days upon infection with P. falciparum in a proportion of subjects. These cells were shown to down-regulate pro-inflammatory responses and to facilitate parasite growth in vivo. However, it is unknown if natural exposure to malaria activates/induces T regulatory cells.In addition to the ongoing case control study exploring a potential role of Tregs in conferring clinical immunity to malaria (SCC 1002) we aim to explore the mode of action of these cells, and will investigate how Tregs get induced upon stimulation with malaria parasites.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-12-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>512246</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081994</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>